[{"address1": "3940 Trust Way", "city": "Hayward", "state": "CA", "zip": "94545", "country": "United States", "phone": "510 780 0819", "website": "https://benitec.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Benitec Biopharma Inc., a clinical-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference-based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy. The company was incorporated in 1995 and is headquartered in Hayward, California.", "fullTimeEmployees": 16, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jerel A. Banks M.D., Ph.D.", "age": 47, "title": "Executive Chairman & CEO", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 848068, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Megan Joan Boston B.Com., C.A.", "age": 50, "title": "Executive Director", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 439168, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael  Graham", "title": "Head of Discovery & Founding Scientist", "fiscalYear": 2023, "totalPay": 127179, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Claudia  Kloth Ph.D.", "title": "Senior Vice President of Manufacturing", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 8.69, "open": 8.845, "dayLow": 8.65, "dayHigh": 9.15, "regularMarketPreviousClose": 8.69, "regularMarketOpen": 8.845, "regularMarketDayLow": 8.65, "regularMarketDayHigh": 9.15, "beta": 0.914, "forwardPE": -4.841398, "volume": 17146, "regularMarketVolume": 17146, "averageVolume": 37350, "averageVolume10days": 27750, "averageDailyVolume10Day": 27750, "bid": 6.56, "ask": 11.09, "bidSize": 200, "askSize": 200, "marketCap": 90825328, "fiftyTwoWeekLow": 2.33, "fiftyTwoWeekHigh": 10.88, "priceToSalesTrailing12Months": 12975.047, "fiftyDayAverage": 8.30138, "twoHundredDayAverage": 5.59479, "currency": "USD", "enterpriseValue": 69862640, "floatShares": 4870999, "sharesOutstanding": 10086100, "sharesShort": 83116, "sharesShortPriorMonth": 9531, "sharesShortPreviousMonthDate": 1718323200, "dateShortInterest": 1721001600, "sharesPercentSharesOut": 0.0089, "heldPercentInsiders": 0.086210005, "heldPercentInstitutions": 0.61675, "shortRatio": 1.89, "shortPercentOfFloat": 0.0095999995, "bookValue": 4.221, "priceToBook": 2.1333807, "lastFiscalYearEnd": 1688083200, "nextFiscalYearEnd": 1719705600, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -21692000, "trailingEps": -9.6, "forwardEps": -1.86, "lastSplitFactor": "2:3", "lastSplitDate": 1586908800, "enterpriseToRevenue": 9980.377, "enterpriseToEbitda": -3.263, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "BNTC", "underlyingSymbol": "BNTC", "shortName": "Benitec Biopharma Inc.", "longName": "Benitec Biopharma Inc.", "firstTradeDateEpochUtc": 1403616600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "b3cc27a2-16b5-3a55-8f58-57577c96b7a7", "gmtOffSetMilliseconds": -14400000, "currentPrice": 9.005, "targetHighPrice": 30.0, "targetLowPrice": 13.0, "targetMeanPrice": 19.67, "targetMedianPrice": 16.0, "recommendationMean": 1.7, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 14143000, "totalCashPerShare": 1.51, "ebitda": -21410000, "totalDebt": 354000, "quickRatio": 4.13, "currentRatio": 4.18, "totalRevenue": 7000, "debtToEquity": 3.078, "revenuePerShare": 0.003, "returnOnAssets": -1.15703, "returnOnEquity": -2.6758802, "freeCashflow": -11906500, "operatingCashflow": -20205000, "grossMargins": 16.42857, "operatingMargins": -3070.2856, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-08-12"}]